Phibro Animal Health (PAHC) Interest & Investment Income (2012 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Interest & Investment Income of -$10.4 million in Q1 2026, up 11.27% quarter-over-quarter from -$11.8 million in Q4 2025, and down 3600.34% on a YoY basis from $298000.0 in Q1 2025.
Phibro Animal Health (PAHC) Interest & Investment Income (2012 - 2026) Analysis & Trends
Phibro Animal Health's Interest & Investment Income history runs 9 years deep, the most recent figure standing at -$10.4 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 3600.34% year-over-year to -$10.4 million; the TTM figure through Mar 2026 stood at -$71.1 million (down 706.71% YoY), while the FY2025 annual figure was -$34.6 million, down 873.4% from the prior year.
- Interest & Investment Income was -$10.4 million for Q1 2026 at Phibro Animal Health, up from -$11.8 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $18.3 million in Q2 2024 to a low of -$36.8 million in Q2 2025.
- Historically, Interest & Investment Income has averaged -$6.1 million across 4 years, with a median of -$4.7 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Interest & Investment Income soared 116.78% in 2024, then tumbled 3600.34% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at -$4.7 million in 2023, then jumped by 116.78% to $782000.0 in 2024, then plunged by 1603.32% to -$11.8 million in 2025, then grew by 11.27% to -$10.4 million in 2026.
- The last three Interest & Investment Income figures came in at -$10.4 million (Q1 2026), -$11.8 million (Q4 2025), and -$12.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Phibro Animal Health | 1.26 Bn | 1.19 Bn | 125.68 Mn | -10.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.43 Mn |
| Dec 31, 2025 | -11.76 Mn |
| Sep 30, 2025 | -12.06 Mn |
| Jun 30, 2025 | -36.81 Mn |
| Mar 31, 2025 | 298,000.00 |
| Dec 31, 2024 | 782,000.00 |
| Sep 30, 2024 | -7.64 Mn |
| Jun 30, 2024 | 18.27 Mn |
| Mar 31, 2024 | -4.58 Mn |
| Dec 31, 2023 | -4.66 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Mar 31, 2016 | -4.27 Mn |
| Dec 31, 2015 | -3.97 Mn |
| Sep 30, 2015 | -3.82 Mn |
| Jun 30, 2015 | 10.86 Mn |
| Mar 31, 2015 | -3.60 Mn |
| Dec 31, 2014 | -3.52 Mn |
| Sep 30, 2014 | -3.49 Mn |
| Jun 30, 2014 | -59,000.00 |
| Mar 31, 2014 | 66,000.00 |